Literature DB >> 12239237

Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury.

Takaharu Tanaka1, Takashi Kuroiwa, Hidekazu Ikeuchi, Fumie Ota, Yoriaki Kaneko, Kazue Ueki, Yoshito Tsukada, Iain B McInnes, Dimitrios T Boumpas, Yoshihisa Nojima.   

Abstract

Platelets are thought to play an important role in the initiation and the progression of a variety of glomerulonephritides. This study examined whether platelets induce production of monocyte chemoattractant protein-1 (MCP-1), a chemokine involved in leukocyte recruitment and glomerular injury, by cultured human mesangial cells (MC). To this end, platelets isolated from normal human donors were cocultured with MC at various ratios. MCP-1 synthesis was evaluated by quantitative real-time PCR and enzyme-linked immunosorbent assay. Platelets at 1:100 ratio (MC to platelets) induced an approximately 20-fold increase in mesangial MCP-1 mRNA and protein expression through an obligatory cell-to-cell contact-dependent mechanism. Importantly, blockade of the CD40/CD40 ligand (CD40L) pathway with neutralizing antibodies decreased MCP-1 production by approximately 60%. It was confirmed that CD40 was functionally expressed on MC. Gel-shift assays and inhibitors of phosphorylation were used to demonstrate that activation of p38 mitogen-activated protein kinase, protein tyrosine kinases, and nuclear factor-kappa B activation were essential for MCP-1 production. These data indicate that platelet/MC contact stimulates the production of MCP-1 and may contribute to glomerular inflammatory responses by recruiting leukocytes from the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239237     DOI: 10.1097/01.asn.0000029588.07166.20

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

Review 1.  New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.

Authors:  Marc Scherlinger; Vanja Sisirak; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Patrick Blanco
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

2.  Platelet and soluble CD40L in meningococcal sepsis.

Authors:  David P Inwald; Saul N Faust; Paula Lister; Mark J Peters; Michael Levin; Robert Heyderman; Nigel J Klein
Journal:  Intensive Care Med       Date:  2006-06-30       Impact factor: 17.440

3.  A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation.

Authors:  Marianne Delville; Tara K Sigdel; Changli Wei; Jing Li; Szu-Chuan Hsieh; Alessia Fornoni; George W Burke; Patrick Bruneval; Maarten Naesens; Annette Jackson; Nada Alachkar; Guillaume Canaud; Christophe Legendre; Dany Anglicheau; Jochen Reiser; Minnie M Sarwal
Journal:  Sci Transl Med       Date:  2014-10-01       Impact factor: 17.956

Review 4.  Platelets: active players in the pathogenesis of arthritis and SLE.

Authors:  Eric Boilard; Patrick Blanco; Peter A Nigrovic
Journal:  Nat Rev Rheumatol       Date:  2012-08-07       Impact factor: 20.543

5.  Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study.

Authors:  Hugo Tannus Furtado de Mendonça-Filho; Kelly Cristina Pereira; Mariane Fontes; Daniel Augusto de Souza Aranha Vieira; Maria Lucia A Furtado de Mendonça; Luiz Antonio de Almeida Campos; Hugo Caire Castro-Faria-Neto
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.

Authors:  Sophie Doublier; Cristina Zennaro; Luca Musante; Tiziana Spatola; Giovanni Candiano; Maurizio Bruschi; Luca Besso; Massimo Cedrino; Michele Carraro; Gian Marco Ghiggeri; Giovanni Camussi; Enrico Lupia
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.